This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EAS | Ann: Change of Director's Interest Notice | 25/03/19 | 1 | 91 | |||
|
|||||||
EAS | Ann: Change of Director's Interest Notice | 14/03/19 | 0 | 72 | |||
|
|||||||
EAS | Ann: 2018/19 First Half Results | 22/02/19 | 1 | 213 | |||
|
|||||||
EAS | Ann: 2018/19 First Half Results Presentation | 21/02/19 | 0 | 130 | |||
|
|||||||
EAS | Ann: Dividend/Distribution - EAS | 21/02/19 | 0 | 89 | |||
|
|||||||
EAS | Ann: Appendix 4D Half Year Report for period ending 31 Dec 2018 | 21/02/19 | 0 | 101 | |||
|
|||||||
EAS | Ann: Cancellation of shares ASIC form 484 | 19/02/19 | 0 | 87 | |||
|
|||||||
EAS | Ann: Revised Security Trading Policy | 13/02/19 | 0 | 109 | |||
|
See All Discussions